Kei Yamada

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
KONICA MINOLTA BUSINESS TECHNOLOGIES, INC.
2
1
2
2009
2010
2013
WASEDA UNIVERSITY
2
2010
NIPPON SHEET GLASS CO., LTD.
1
2
2004
2005
LAPIS SEMICONDUCTOR CO., LTD.
2
2003
OKI ELECTRIC INDUSTRY CO., LTD.
2
2010
Konica Corporation
4
5
2
2001
2002
2006
KONICA MINOLTA, INC.
4
2015
NGK INSULATORS, LTD.
1
1979

Inventor Addresses

AddressDuration
Atsugi, JPJul 16, 13 - Jul 16, 13
Atsugi-shi, JPDec 23, 10 - Dec 23, 10
Hachioji, JPMay 27, 08 - May 27, 08
Hino, JPDec 26, 17 - Dec 26, 17
Hyogo, JPOct 15, 15 - Jan 23, 18
Kanagawa, JPFeb 22, 24 - Feb 22, 24
Kawanishi, JPMar 08, 16 - Mar 08, 16
Kawanishi-shi, JPSep 12, 13 - Sep 12, 13
Kawasaki, JPJul 02, 24 - Jul 02, 24
Kawasaki-shi, JPJun 18, 20 - Nov 07, 24
Nagoya, JPMar 16, 82 - Mar 16, 82
Saitama, JPJun 16, 11 - Apr 16, 13
Seki-shi, Gifu, JPDec 13, 18 - Dec 13, 18
Tokyo, JPDec 27, 01 - Apr 07, 16
Yokkaichi, JPDec 26, 23 - Dec 26, 23
Yokkaichi, Mie, JPOct 10, 19 - Oct 10, 19
Yokkaichi-shi, Mie, JPSep 15, 22 - Sep 15, 22

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6
B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF SUBSTANCES IN A PLASTIC STATE, IN GENERAL; AFTER- TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1
B41B: MACHINES OR ACCESSORIES FOR MAKING, SETTING, OR DISTRIBUTING TYPE; TYPE; PHOTOGRAPHIC OR PHOTOELECTRONIC COMPOSING DEVICES 2

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2024/0366,7832024COMPOUND HAVING AFFINITY SUBSTANCE TO SOLUBLE PROTEIN, CLEAVABLE PORTION AND REACTIVE GROUP, OR SALT THEREOF0
2024/0218,0152024METHODS FOR PRODUCING INTERMEDIATE ANTIBODIES REGIOSELECTIVELY MODIFIED, AND ANTIBODY DERIVATIVES REGIOSELECTIVELY HAVING BIOORTHOGONAL FUNCTIONAL GROUP OR FUNCTIONAL SUBSTANCE0
120245492024Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereof0
2024/0115,7192024COMPOUND OR SALT THEREOF, AND ANTIBODY OBTAINED BY USING THE SAME0
2024/0058,4732024COMPLEX OR SALT THEREOF, AND METHOD FOR PRODUCING THE SAME0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.